21 CFR Part 11 electronic signatures
In some regions, it is already expected that users re-authorise themselves to do important functions, submitting, verifying and publishing results, and configuring critical objects, as stipulated by Title 21 of the Code of Federal Regulations that establishes the United States Food and Drug Administration (FDA) regulations on electronic records and electronic signatures (ERES)